TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN

AC T10279 XX ID T10279 XX DT 10.03.2005 (created); nvo. DT 30.07.2015 (updated); hna. CO Copyright (C), QIAGEN. XX FA Pax-3 XX SY PAX3. XX OS Mammalia OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia XX IN T02944 Daxx; human, Homo sapiens. IN T11408 Meox2; rat, Rattus norvegicus. IN T09349 Mox1; mouse, Mus musculus. IN T30717 Pax-7; Mammalia. IN T00630 POU3F2; human, Homo sapiens. IN T25008 pRb; Mammalia. IN T10436 Sox-10; Mammalia. IN T14175 TBP; Mammalia. XX MX M00360 V$PAX3_01. MX M00327 V$PAX3_B. MX M00808 V$PAX_Q6. XX BS R62513. BS R72399. BS R30332. BS R29882. BS R63777. BS R30333. BS R66674. BS R69026. BS R69027. BS R69032. BS R69036. BS R69041. BS R69042. BS R69047. BS R69049. BS R69055. BS R69056. BS R34262. BS R22917. BS R22918. XX DR TRANSPATH: MO000047544. XX RN [1]; RE0005940. RX PUBMED: 9094722. RA Maroto M., Reshf R., Muensterberg A. E., Koester S., Goulding M., Lassar A. B. RT Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue RL Cell 89:139-148 (1997). RN [2]; RE0007031. RX PUBMED: 8633043. RA Epstein J. A., Shapiro D. N., Cheng J., Lam P. Y. P., Maas R. L. RT Pax3 modulates expression of the c-Met receptor during limb muscle development. RL Proc. Natl. Acad. Sci. USA 93:4213-4218 (1996). RN [3]; RE0014042. RX PUBMED: 10393185. RA Hollenbach A. D., Sublett J. E., McPherson C. J., Grosveld G. RT The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx RL EMBO J. 18:3702-3711 (1999). RN [4]; RE0014085. RX PUBMED: 9464541. RA Wiggan O., Taniguchi-Sidle A., Hamel P. A. RT Interaction of the pRB-family proteins with factors containing paired-like homeodomains RL Oncogene 16:227-236 (1998). RN [5]; RE0024470. RX PUBMED: 12668617. RA Lang D., Epstein J. A. RT Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. RL Hum. Mol. Genet. 12:937-945 (2003). RN [6]; RE0031269. RX PUBMED: 11997098. RA Hollenbach A. D., McPherson C. J., Lagutina I., Grosveld G. RT The EF-hand calcium-binding protein calmyrin inhibits the transcriptional and DNA-binding activity of Pax3. RL Biochim. Biophys. Acta 1574:321-8 (2002). RN [7]; RE0039302. RX PUBMED: 11262400. RA Ridgeway A. G., Skerjanc I. S. RT Pax3 is essential for skeletal myogenesis and the expression of six1 and eya2 RL J. Biol. Chem. 276:19033-9 (2001). RN [8]; RE0045440. RX PUBMED: 9601985. RA Hill A. L., Phelan S. A., Loeken M. R. RT Reduced expression of pax-3 is associated with overexpression of cdc46 in the mouse embryo RL Dev. Genes Evol. 208:128-34 (1998). RN [9]; RE0048297. RX PUBMED: 10359315. RA Cvekl A., Kashanchi F., Brady J. N., Piatigorsky J. RT Pax-6 interactions with TATA-box-binding protein and retinoblastoma protein. RL Invest. Ophthalmol. Vis. Sci. 40:1343-1350 (1999). RN [10]; RE0064992. RX PUBMED: 11029584. RA Smit D. J., Smith A. G., Parsons P. G., Muscat G. E., Sturm R. A. RT Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. RL Eur. J. Biochem. 267:6413-6422 (2000). RN [11]; RE0065011. RX PUBMED: 11423130. RA Stamataki D., Kastrinaki M., Mankoo B. S., Pachnis V., Karagogeos D. RT Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors. RL FEBS Lett. 499:274-278 (2001). RN [12]; RE0066671. RX PUBMED: 19026785. RA Yang G., Li Y., Nishimura E. K., Xin H., Zhou A., Guo Y., Dong L., Denning M. F., Nickoloff B. J., Cui R. RT Inhibition of PAX3 by TGF-beta modulates melanocyte viability. RL Mol. Cell 32:554-563 (2008). RN [13]; RE0066940. RX PUBMED: 17662948. RA Boutet S. C., Disatnik M. H., Chan L. S., Iori K., Rando T. A. RT Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors. RL Cell 130:349-362 (2007). XX //